Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 3:48 AM
Ignite Modification Date: 2025-12-26 @ 2:36 AM
NCT ID: NCT00999102
Description: All-Cause Mortality; Serious; Other.
Frequency Threshold: 0
Time Frame: After 4 weeks on either study drug.
Study: NCT00999102
Study Brief: Nebivolol Versus Metoprolol: Comparative Effects on Fatigue and Quality of Life
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Nebivolol 5 mg for 4 Weeks 31 subjects received Nebivolol 5 mg daily for 4 weeks. 0 None 0 33 1 33 View
Metoprolol 50 mg for 4 Weeks 31 subjects received Metoprolol 50 mg daily for 4 weeks 0 None 0 33 1 33 View
Nebivolol 10 mg for 4 Weeks 31 subjects received Nebivolol 10 mg daily for 4 weeks. 0 None 0 33 0 31 View
Metoprolol 100 mg for 4 Weeks 31 subjects received Metoprolol 100 mg daily for 4 weeks 0 None 0 33 0 31 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Fatigue SYSTEMATIC_ASSESSMENT General disorders None View